Fujian Aonong Biological Technology Group Incorporation (603363.SS) Earnings Analysis
Fujian Aonong Biological Technology Group Incorporation (603363.SS) has no confirmed upcoming earnings date. Trailing P/E 68.81.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603363.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 603363.SS. This page updates as the calendar is published.
603363.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-04-29 | 0.2525 CNY | n/a | n/a | n/a |
| 2024-12-31 | 1.47 CNY | n/a | n/a | n/a |
| 2024-08-30 | -0.28495 CNY | n/a | n/a | n/a |
603363.SS valuation and analyst view
| Trailing P/E | 68.81 |
|---|---|
| Trailing EPS | -0.11554 CNY |
| Price / book | 1.20 |
| Dividend yield | 0.00% |
| Market cap | 7.48B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Fujian Aonong Biological Technology Group Incorporation (603363.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 603363.SS. This page updates as the calendar is published.
Did 603363.SS beat earnings last quarter?
Consensus estimate data was not available for 603363.SS's 2025-04-29 report.
What is 603363.SS's current P/E ratio and EPS?
603363.SS trades at a trailing P/E of 68.81 on trailing EPS of -0.11554096015790741 CNY.
What do analysts rate 603363.SS?
603363.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.